Article
Non-canonical integrin signaling activates EGFR and RAS-MAPK-ERK signaling in small cell lung cancer.
Theranostics - 1 Jan 2023
Rubio Karla, Romero-Olmedo Addi J, Sarvari Pouya, Swaminathan Guruprasadh, Ranvir Vikas P, Rogel-Ayala Diana G, Cordero Julio, Günther Stefan, Mehta Aditi, Bassaly Birgit, Braubach Peter, Wygrecka Malgorzata, Gattenlöhner Stefan, Tresch Achim, Braun Thomas, Dobreva Gergana, Rivera Miguel N, Singh Indrabahadur, Graumann Johannes, Barreto Guillermo
Abstract excerpt
Background: Small cell lung cancer (SCLC) is an extremely aggressive cancer type with a patient median survival of 6-12 months. Epidermal growth factor (EGF) signaling plays an important role in triggering SCLC. In addition, growth factor-dependent signals and alpha-, beta-integrin (ITGA, ITGB) heterodimer receptors functionally cooperate and integrate their signaling pathways. However, the precise role of...
Topics
Join the communities discussing this publication.
